DK465986D0 - Fremgangsmaade til foraegelse af produktionen af t-pa (vaevsplasminogenaktivator) og scu-pa (enkeltkaede-urokinase-plasminogenaktivator) - Google Patents

Fremgangsmaade til foraegelse af produktionen af t-pa (vaevsplasminogenaktivator) og scu-pa (enkeltkaede-urokinase-plasminogenaktivator)

Info

Publication number
DK465986D0
DK465986D0 DK465986A DK465986A DK465986D0 DK 465986 D0 DK465986 D0 DK 465986D0 DK 465986 A DK465986 A DK 465986A DK 465986 A DK465986 A DK 465986A DK 465986 D0 DK465986 D0 DK 465986D0
Authority
DK
Denmark
Prior art keywords
plasminogen activator
scu
single chain
procedure
chain urokinase
Prior art date
Application number
DK465986A
Other languages
English (en)
Other versions
DK465986A (da
Inventor
Ruth Rappaport
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of DK465986D0 publication Critical patent/DK465986D0/da
Publication of DK465986A publication Critical patent/DK465986A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Control Of Eletrric Generators (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK465986A 1985-10-01 1986-09-30 Fremgangsmaade til foroegelse af produktionen af t-pa (vaevsplasminogenaktivator) og scu-pa (enkeltkaede-urokinase-plasminogenaktivator) DK465986A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78265885A 1985-10-01 1985-10-01
US07/907,004 US4889808A (en) 1985-10-01 1986-09-17 Method of enchancing t-PA and SCU-PA production

Publications (2)

Publication Number Publication Date
DK465986D0 true DK465986D0 (da) 1986-09-30
DK465986A DK465986A (da) 1987-04-02

Family

ID=27120027

Family Applications (1)

Application Number Title Priority Date Filing Date
DK465986A DK465986A (da) 1985-10-01 1986-09-30 Fremgangsmaade til foroegelse af produktionen af t-pa (vaevsplasminogenaktivator) og scu-pa (enkeltkaede-urokinase-plasminogenaktivator)

Country Status (11)

Country Link
US (1) US4889808A (da)
EP (1) EP0219270B1 (da)
KR (1) KR870004133A (da)
AT (1) ATE73844T1 (da)
AU (1) AU603552B2 (da)
DE (1) DE3684403D1 (da)
DK (1) DK465986A (da)
ES (1) ES2046170T3 (da)
GB (1) GB2181741B (da)
GR (1) GR3004775T3 (da)
HU (1) HU201800B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61221128A (ja) * 1985-03-26 1986-10-01 Snow Brand Milk Prod Co Ltd プラスミノ−ゲン活性化因子に対するモノクロ−ナル抗体とその調製方法及び該モノクロ−ナル抗体の使用方法
US5206223A (en) * 1986-06-26 1993-04-27 Yeda Research And Development Co. Ltd. Method for inhibiting heparanase activity
CA1322163C (en) * 1986-07-03 1993-09-14 Kenneth A. Thomas, Jr. Plasminogen activator production
GB8723082D0 (en) * 1987-10-01 1987-11-04 Porton Prod Ltd Enzyme production
US4957863A (en) * 1988-01-26 1990-09-18 Monsanto Company Method of increasing yield of t-PA in cell culture
AU3364589A (en) * 1988-03-22 1989-10-16 Invitron Corporation Method to enhance tpa production
US5210037A (en) * 1988-03-22 1993-05-11 Centocor Incorporated Method to enhance TPA production
WO1991012317A1 (en) * 1990-02-09 1991-08-22 Genentech, Inc. Lung cell line and methods of use
US5500409A (en) * 1990-10-01 1996-03-19 Thomas Jefferson University Method for inhibiting collagen synthesis by keloid fibroblasts
AU668865B2 (en) * 1991-05-02 1996-05-23 Irun R. Cohen Compositions for the prevention and/or treatment of pathological processes
US6750207B1 (en) * 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
US5861382A (en) * 1992-05-01 1999-01-19 Yeda Research And Development Co. Ltd. Methods for regulation of active TNF-α
US5464815A (en) * 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
AU2001245734A1 (en) * 2000-03-15 2001-09-24 Orbus Medical Technologies Inc. Coating that promotes endothelial cell adherence
US7285536B2 (en) * 2001-12-05 2007-10-23 Yeda Research And Development Co., Ltd. Anti-cancer therapeutic compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
US4520107A (en) * 1982-09-28 1985-05-28 Polydex Chemicals Ltd. Tissue culture and cell growth-promoting material and its method of manufacture
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
US4757005A (en) * 1984-04-19 1988-07-12 Miles Inc. Method and cell line for obtaining plasminogen activators
US4661453A (en) * 1984-06-19 1987-04-28 American Biogenetic Sciences, Inc. Production of tissue plasminogen activator factor
EP0437281B1 (en) * 1984-12-24 1994-04-13 Merck & Co. Inc. Composition comprising acidic fibroblast growth factor (aFGF)
CA1322163C (en) * 1986-07-03 1993-09-14 Kenneth A. Thomas, Jr. Plasminogen activator production
JP2666348B2 (ja) * 1988-04-21 1997-10-22 ソニー株式会社 再生装置

Also Published As

Publication number Publication date
GB2181741A (en) 1987-04-29
GB2181741B (en) 1989-10-18
EP0219270A2 (en) 1987-04-22
US4889808A (en) 1989-12-26
KR870004133A (ko) 1987-05-07
AU6341386A (en) 1987-04-02
HUT42524A (en) 1987-07-28
GR3004775T3 (da) 1993-04-28
ATE73844T1 (de) 1992-04-15
HU201800B (en) 1990-12-28
AU603552B2 (en) 1990-11-22
GB8623615D0 (en) 1986-11-05
ES2046170T3 (es) 1994-02-01
EP0219270B1 (en) 1992-03-18
DE3684403D1 (de) 1992-04-23
DK465986A (da) 1987-04-02
EP0219270A3 (en) 1989-04-05

Similar Documents

Publication Publication Date Title
DK465986A (da) Fremgangsmaade til foroegelse af produktionen af t-pa (vaevsplasminogenaktivator) og scu-pa (enkeltkaede-urokinase-plasminogenaktivator)
DK0642580T3 (da) Hepactocytvækstfaktorvarianter
DK1220934T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner med anvendelse af apoptoseinhibitorer
IL68366A (en) Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture
DE3889665D1 (de) Serumfreie wachstumsmedien für insektenzellen und expression von produkten damit.
DE69133263D1 (de) Klonierung und expression von biologisch aktiver alpha-n-acetylgalaktosaminidase
DK1242578T3 (da) Celledyrkningsmedium indeholdende vækstfaktorer og L-glutamin
ES8802442A1 (es) Un procedimiento para preparar un polimero de adn.
KR890003952A (ko) 신규 조직 플라스미노겐 활성제
ES8800347A1 (es) Metodo para preparar uroquinasa de una sola cadena resistente a proteasas
DK0502872T3 (da) Fremgangsmåder og materialer til eksprimering af human plasminogenvariant
ATE62512T1 (de) Verfahren zur bestimmung von plasminogenaktivatoren (pa).
FI915149A0 (fi) Foerfarande och material foer expression av humant plasminogen i ett eukaryotiskt cellsystem som saknar en laegesspecifik plasminogenaktivator.
DK506683A (da) Fibrinolytiske enzymer, fremgangsmaader til fremstilling deraf og farmaceutiske midler indeholdende dem
ES8603951A1 (es) Un metodo de estabilizar el zimogeno de uroquinasa
KR890701732A (ko) 개량형 조직 플라스미노겐 활성화 인자
IE890270L (en) Proteins derived from human alpha 2 plasmin inhibitor
ES8705466A1 (es) Un metodo para la preparacion del factor nkbs regulador del cancer humano.
ES2066733A1 (es) Complejo consistente en un activador del plasminogeno y albumina de suero y procedimiento para prepararlo.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment